CHRU Tours — Tours

Public research footprint of CHRU Tours, compiled from the ClinicalTrials.gov public registry.

170

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Multiple Myeloma · Oropharyngeal Squamous Cell Carcinoma · Head and Neck Cancer · Kidney Transplant Rejection

Recently updated registry entries

NCT04736381 — Impact of the Microbiota on the Likelihood of Renal Graft Rejection (Active Not Recruiting)
NCT03145181 — Dose Escalation Study of Teclistamab, a Humanized BCMA*CD3 Bispecific Antibody, in… (Active Not Recruiting)
NCT03767244 — A Study of Apalutamide in Participants With High-Risk, Localized or Locally Advanced… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHRU Tours?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.